Company · CIK 0001531177 · SIC 3841 — Surgical & Medical Instruments & Apparatus · Nasdaq
Sight Sciences, Inc. · SGHT
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 AForm 4 → | Aug 18, 6:08 pm EDT | Kashif RashidChief Legal Officer | 181,818 | — | — | 181,818 | — | late |
| Jul 6, 2026 SForm 4 → | Jul 6, 7:36 pm EDT | Jeremy B. HaydenChief Legal Officer | 12,733 | $5.51 | $70,133 | 357,037 | −3.44% | 10b5-1 |
| Jul 6, 2026 SForm 4 → | Jul 6, 7:34 pm EDT | David BadawiChief Technology Officer, Director | 7,418 | $5.51 | $40,858 | 1,982,872 | −0.37% | 10b5-1 |
| Jul 2, 2026 SForm 4 → | Jul 6, 7:36 pm EDT | James RodbergChief Financial Officer | 6,902 | $5.36 | $36,995 | 224,037 | −2.99% | 10b5-1 |
| Jul 2, 2026 SForm 4 → | Jul 6, 7:32 pm EDT | Alison BauerleinChief Operating Officer | 24,184 | $5.36 | $129,626 | 664,709 | −3.51% | 10b5-1 |
| Jul 1, 2026 SForm 4 → | Jul 6, 7:33 pm EDT | Brenton TaylorEVP, Operations & R&D | 2,829 | $5.42 | $15,333 | 264,978 | −1.06% | 10b5-1 |
| Jul 1, 2026 SForm 4 → | Jul 6, 7:31 pm EDT | Paul BadawiPresident and CEO, Director, 10% Owner | 28,684 | $5.42 | $155,467 | 6,122,472 | −0.47% | 10b5-1 |
| Jun 10, 2026 PForm 4 → | Jun 11, 4:43 pm EDT | Staffan EncrantzDirector, 10% Owner | 14,100 | $4.88 | $68,794 | 1,434,283 | +0.99% | |
| Jun 4, 2026 AForm 4 → | Jun 5, 4:10 pm EDT | Tamara FountainDirector | 28,261 | — | — | 109,650 | — | |
| Jun 4, 2026 AForm 4 → | Jun 5, 4:10 pm EDT | Staffan EncrantzDirector, 10% Owner | 28,261 | — | — | 1,420,183 | — | |
| Jun 4, 2026 AForm 4 → | Jun 5, 4:10 pm EDT | Gerhard F BurbachDirector | 28,261 | — | — | 123,207 | — | |
| Jun 4, 2026 AForm 4 → | Jun 5, 4:09 pm EDT | Donald ZurbayDirector | 28,261 | — | — | 193,613 | — | |
| Jun 4, 2026 AForm 4 → | Jun 5, 4:09 pm EDT | Catherine MazzaccoDirector | 28,261 | — | — | 69,276 | — |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.